Stereotaxis has announced the successful first procedures by physicians at Erasmus University Medical Center in Rotterdam, The Netherlands, using the company’s Genesis robotic magnetic navigation system.
“We have long recognised the clinical benefits of robotics, and are delighted to be the first in The Netherlands to make the Genesis robotic system available to cardiovascular patients,” said Sing-Chien Yap (Erasmus Medical Center, Rotterdam, The Netherlands). “We are impressed with the speed and responsiveness of Genesis. Combined with the Magic catheter, we are particularly pleased with the synergistic additive improvements to robotic magnetic navigation. These technological advances are important in ensuring we can offer the best care to all arrhythmia patients, including children, patients with congenital heart disease, and patients with complex arrhythmia.”
Erasmus Medical Center is described in a press release as a global leader in using robotic magnetic navigation for complex arrhythmia procedures, having performed more than 4,500 procedures with Stereotaxis’ technologies.
The Genesis system is the latest advancement in Robotic magnetic navigation technology, introducing the benefits of robotic precision and safety to cardiac ablation.
“We appreciate our long-term partnership with the electrophysiology team at Erasmus,” said David Fischel, Stereotaxis’ chairman and chief executive officer (CEO). “We look forward to continuing to support their successful robotic programme, and working together to advance technological progress, scientific discovery and clinical care.”
